These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38409536)

  • 21. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
    Gois LCP; Pimentel-Silva LR; Damasceno BP; Damasceno A
    Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sleep and Cognitive Function in Multiple Sclerosis.
    Braley TJ; Kratz AL; Kaplish N; Chervin RD
    Sleep; 2016 Aug; 39(8):1525-33. PubMed ID: 27166237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability.
    Has Silemek AC; Fischer L; Pöttgen J; Penner IK; Engel AK; Heesen C; Gold SM; Stellmann JP
    Neuroimage Clin; 2020; 25():102177. PubMed ID: 32014828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients.
    Conway DS; Planchon SM; Oh SH; Nakamura K; Thompson NR; Sakaie K; Ontaneda D
    Mult Scler Relat Disord; 2021 Jan; 47():102635. PubMed ID: 33260053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
    Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Squitieri F; Curcio G; Landi D; Palmieri MG; Moffa F; Filippi MM; Vernieri F
    Behav Neurol; 2017; 2017():7404289. PubMed ID: 28912625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
    Planche V; Gibelin M; Cregut D; Pereira B; Clavelou P
    Eur J Neurol; 2016 Feb; 23(2):282-9. PubMed ID: 25903918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Association between depression and cognitive decline in sclerosis multiplex patients].
    Hegedüs K; Kárpáti J; Szombathelyi É; Simó M
    Neuropsychopharmacol Hung; 2015 Mar; 17(1):31-6. PubMed ID: 25935381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive phenotypes in multiple sclerosis.
    Leavitt VM; Tosto G; Riley CS
    J Neurol; 2018 Mar; 265(3):562-566. PubMed ID: 29356970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of neuropsychological impairment in the early phase of relapsing-remitting multiple sclerosis.
    Olivares T; Nieto A; Sánchez MP; Wollmann T; Hernández MA; Barroso J
    Mult Scler; 2005 Apr; 11(2):191-7. PubMed ID: 15794394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What Are the Minimal Detectable Changes in SDMT and Verbal Fluency Tests for Assessing Changes in Cognitive Performance in Persons with Multiple Sclerosis and Non-Multiple Sclerosis Controls?
    Magnin E; Sagawa Y; Moulin T; Decavel P
    Eur Neurol; 2020; 83(3):263-270. PubMed ID: 32634812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The subtleties of cognitive decline in multiple sclerosis: an exploratory study using hierarchichal cluster analysis of CANTAB results.
    Cabeça HLS; Rocha LC; Sabbá AF; Tomás AM; Bento-Torres NVO; Anthony DC; Diniz CWP
    BMC Neurol; 2018 Sep; 18(1):140. PubMed ID: 30200902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of a brief cross-cultural cognitive screening test in Multiple Sclerosis.
    Delgado-Álvarez A; Delgado-Alonso C; Goudsmit M; Gil MJ; Díez-Cirarda M; Valles-Salgado M; Montero-Escribano P; Hernández-Lorenzo L; Matías-Guiu J; Matias-Guiu JA
    Mult Scler Relat Disord; 2022 Nov; 67():104091. PubMed ID: 35963204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients.
    Wuerfel E; Weddige A; Hagmayer Y; Jacob R; Wedekind L; Stark W; Gärtner J
    PLoS One; 2018; 13(3):e0194873. PubMed ID: 29566099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis.
    Gaudino EA; Chiaravalloti ND; DeLuca J; Diamond BJ
    Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):32-44. PubMed ID: 11234907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Information processing speed and influential factors in multiple sclerosis].
    Zhang ML; Xu EH; Dong HQ; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of cognitive reserve in multiple sclerosis: A cross-sectional study in 526 patients.
    Artemiadis A; Bakirtzis C; Ifantopoulou P; Zis P; Bargiotas P; Grigoriadis N; Hadjigeorgiou G
    Mult Scler Relat Disord; 2020 Jun; 41():102047. PubMed ID: 32182469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple brain networks support processing speed abilities of patients with multiple sclerosis.
    Manca R; Mitolo M; Stabile MR; Bevilacqua F; Sharrack B; Venneri A
    Postgrad Med; 2019 Sep; 131(7):523-532. PubMed ID: 31478421
    [No Abstract]   [Full Text] [Related]  

  • 39. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does multilingualism act as a protective factor (cognitive reserve) against cognitive impairment in multiple sclerosis?: A retrospective cohort study.
    Morrow SA; Balusha AAK; Rosehart H; Casserly C; Racosta JM
    Mult Scler Relat Disord; 2023 Dec; 80():105060. PubMed ID: 37866025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.